This activity is supported by an educational grant from Akcea Therapeutics™ A Subsidiary of Ionis Pharmaceuticals, Inc.
Endorsed by: The National Pancreas Foundation.
Familial chylomicronemia syndrome (FCS) is a rare and potentially life-threatening genetic disease. The clinical…
January 3, 2018
More than 80% of patients who underwent fecal microbiota transplantation, or FMT, were free of Clostridium difficile…